Christopher Peetz
Board Member
Arcutis Biotherapeutics, Inc. (ARQT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Christopher Peetz
Christopher Peetz is recorded as Board Member at Arcutis Biotherapeutics, Inc. (ARQT). Arcutis Biotherapeutics, Inc. reported in an 8-K filed July 16, 2026 that Christopher Peetz was appointed Class III director, effective July 15, 2026.
“On July 15, 2026, the Board of Directors (the "Board") of Arcutis Biotherapeutics, Inc. (the "Company") increased the authorized number of directors on the Board from nine to ten directors and appointed Mr. Christopher Peetz as a new member of the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-07-15–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Arcutis Biotherapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Todd Franklin Watanabe CEO, Board Member
- Latha Vairavan CFO
- Masaru Matsuda General Counsel
- David Topper Chief Accounting Officer
- Scott Burrows Chief Accounting Officer
- Amit D. Munshi Board Member
- Chris Peetz Board Member
- Halley E. Gilbert Board Member
- Howard G. Welgus Board Member
- Howard Welgus, M.D., FAAD Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.